http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
-
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
-
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
-
Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results
-
Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results
-
Enzo Biochem (ENZ) to Sell Clinical Laboratory to Labcorp
-
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
-
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
-
Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update
-
Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th
-
Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th
-
Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting
-
Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting
-
Enzo Biochem (ENZ) Appoints Patricia Eckert, CPA as Interim CFO
-
Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO
-
Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO
-
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
-
Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th
-
Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th
-
Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
-
Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
-
Enzo Biochem (ENZ) Launches AMPIVIEW Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2
-
Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2
-
Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2
-
Enzo Biochem (ENZ) to Launch Monkeypox Testing Services this Week
-
Enzo Biochem to Launch Monkeypox Testing Services this Week
-
Enzo Biochem to Launch Monkeypox Testing Services this Week
-
Enzo Biochem Appoints Matthew Kupferberg as General Counsel
-
Enzo Biochem Appoints Matthew Kupferberg as General Counsel
-
Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor
-
UPDATE -- Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
-
UPDATE -- Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
-
Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
-
Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
-
Enzo Biochem (ENZ) Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test
-
Enzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test
-
Enzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test
-
Enzo Biochem Reports Results of its Annual Meeting of Shareholders
-
Enzo Biochem Reports Results of its Annual Meeting of Shareholders
-
Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal
-
Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal
-
Enzo Biochem Adjourns Annual Meeting of Shareholders Until April 8, 2022
-
Enzo Biochem Adjourns Annual Meeting of Shareholders Until April 8, 2022
-
Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions
-
Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions
-
Enzo Biochem Reports Second Quarter Fiscal 2022 Result and Provides Leadership and Corporate Updates
-
Enzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
-
Enzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
-
Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th
-
Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th

